Home Renal Therapy Mobile Platform for Patient Compliance Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Patients often become disengaged from self-administered medical treatments over time, leading to gaps in clinical oversight and potential health risks due to omitted tasks and reduced enthusiasm.
Innovation Solution
A medical fluid data transfer system using a mobile platform that provides patients with increased feedback and control over their treatment, automates data gathering, and enables real-time communication with clinicians, enhancing engagement and compliance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If patients perform self-administered medical treatments at home, then treatment accessibility and convenience are improved, but patient engagement and compliance deteriorate over time
Solution Approach 1:
The system implements bidirectional communication between the medical fluid delivery device and the patient's mobile device, providing real-time feedback on treatment status, fluid consumption, and therapy parameters. This feedback loop keeps patients informed and engaged with their treatment progress, counteracting the natural decline in enthusiasm that occurs with long-term self-administered therapy
Solution Approach 2:
A mobile communication device serves as an intermediary between the patient and the medical fluid delivery device, and also between the patient and the clinician. This intermediary enhances patient engagement by providing a user-friendly interface for monitoring treatment and facilitates remote clinical oversight, thereby improving compliance without requiring direct patient-clinician contact for every treatment session
2Reliability
If patients manually record treatment data, then clinical oversight is maintained, but patient burden and complexity increase
Solution Approach 1:
The medical fluid delivery device automatically performs data collection and recording functions, including tracking fluid consumption, monitoring treatment parameters, and storing therapy information. This self-service capability eliminates the need for patients to manually record treatment data, significantly reducing the burden and complexity associated with data entry while maintaining complete and accurate treatment records for clinical review
Solution Approach 2:
The system replaces manual data recording (mechanical/paper-based process) with automated electronic data capture and transmission. The device automatically transmits treatment data to both local storage and remote clinician access points, substituting the manual writing and filing process with electronic automation, thereby reducing patient burden while ensuring data integrity for clinical oversight
3Reliability
If clinicians review all treatment data, then treatment safety is ensured, but time and resource consumption increase
Solution Approach 1:
The system implements selective data transmission where only relevant treatment information is sent to clinicians based on predefined criteria such as abnormal parameters, treatment completion status, or clinically significant events. This partial action approach ensures that clinicians receive sufficient information to maintain treatment safety without being overwhelmed by complete raw data sets, thereby reducing review time while preserving essential safety monitoring
Data Source
AI summary
A platform for patient engagement and treatment compliance is disclosed. In an example, a system includes a home therapy machine configured to perform a renal failure therapy treatment. The system also includes a mobile communication device including an application that enables a patient to select a program type for a future renal failure therapy treatment. The application is configured to determine a short program and a long program are available for the future renal failure therapy treatment and cause a user interface to provide an option to select one of the short program or the long program. The application is also configured to receive a selection of the short program or the long program via the user interface and transmit a message to the home therapy machine, the message indicative of the selection of the short program or the long program for the future renal failure therapy treatment.